Persistent infection with Japanese encephalitis virus (JEV) was established in murine neuroblastoma N18 cells, and the persistency has been maintained in cell culture for over 6 months. From the persistently infected cells, a clone named C2-2 was selected and expanded to form a stable cell line. The vast majority of C2-2 cells showed viral protein staining by immunofluorescence and continuously produced low levels of virus (10 3 to 10 4 PFU/ml) without marked cytopathic effects or cyclic variations. In addition to the wild-type viral proteins, truncated forms of the viral nonstructural protein 1 (NS1) as well as its derivative NS1 were produced in C2-2 cells. Both truncated NS1 and NS1 contain deletions at their N-termini; however, the analyses by RT-PCR and direct sequencing of the viral RNA failed to detect any truncations or mutations within the NS1 region, suggesting that NS1 truncation was a result of a unique posttranslational proteolytic cleavage of NS1 in the persistently infected cells. Similar but not identical truncation of NS1 was also observed in two other persistently infected cell lines established in Vero and DBT (murine astrocytoma) cells. However, viruses released from C2-2 cells did not produce truncated NS1 upon infection of N18 cells, suggesting that NS1 truncations were the result of virus-cell interaction in persistently infected cells. These data indicate a strong association between abnormal NS1 expression and JEV persistency. A probable involvement of dysfunctional NS1 in the establishment and/or maintenance of JEV persistency in tissue culture is discussed. ᭧
INTRODUCTION 5-C-prM(M)-E-NS1-NS2A2B-NS3-NS4A4B-NS5-3.
The nonstructural proteins in JEV-infected cells comJapanese encephalitis virus (JEV) is a member of the prise a glycosylated NS1; two hydrophilic proteins, NS3 Flaviviridae and causes acute encephalitis in humans and NS5; and four small hydrophobic proteins, NS2A, with a high mortality rate (Burke and Leake, 1988 ; Vaughn NS2B, NS4A, and NS4B, associated with the cellular and Hoke, 1992). Similar to the majority of viruses in this membrane (Hashimoto et al., 1990; Nitayaphan et al., family, JEV is arthropod-borne and transmitted to human 1990; Sumiyoshi et al., 1987) . NS1 has a predicted molecthrough persistently infected mosquito vectors. In the ular weight of 42 kDa, with two N-linked carbohydrate natural life cycle of JEV, human is the dead-end host, chains at positions 105 and 182; however, the actual size while other vertebrates, such as swine, serve as an amof NS1 in JEV-infected cells is approximately 48 kDa. plifying reservoir for the maintenance of JEV (Chambers The proteolytic cleavage of E-NS1 is followed by the et al ., 1990) .
translocation of NS1 into the lumen of the endoplasmic The JEV genome is a single-stranded, positive-sense reticulum (ER), and the cleavage of NS1-2A is thought RNA of approximately 11 kb and contains an open readto take place in the lumen of vesicular compartments ing frame of more than 10 kb encoding a polyprotein (Chambers et al., 1990 ). An additional NS1-2A-related (reviewed in Chambers et al., 1990) . In the infected cells, protein (named as NS1) of 56 kDa is often observed the polyprotein is proteolytically cleaved by cellular and in JEV-infected cells (Mason, 1989) and is presumably viral proteases into more than 10 viral proteins. The strucgenerated by a protease which recognizes an alternative tural proteins, including capsid (C), precursor of memcleavage site within NS2A (Jan et al., 1995) . It has been brane (prM), and envelope (E), are encoded in the 5 suggested that NS1 may play a role in virion maturation, quarter of the genome, and the nonstructural proteins, since NS1 is coretained with the immature forms of the designated NS1 through NS5, are encoded in the remainstructural glycoprotein E in the ER of JEV-infected cells (Fan and Mason, 1990) . Nonetheless, the exact biological functions of NS1 and NS1 in JEV replication remain un-1 To whom correspondence and reprint requests should be adclear. tent infection has been demonstrated in cell cultures counted, diluted with medium, and distributed into a 96-well microtiter plate. Each well, which contained an aver- Blair, 1977, 1979; Shah and Gadkari, 1987) as well as in a mouse model (Mathur et al., 1986) . age of one cell, was microscopically observed daily for the presence of cell colonies. Once they became confluMoreover, in the human, latent infection of mononuclear cells in the peripheral blood from JEV-infected patients ent in wells, cells were trypsinized and transferred to new 25-cm tissue culture flasks for further growth. has been documented (Sharma et al., 1991) ; viral persistency in the human nervous system has been shown in Generation and characterization of monoclonal approximately 5% of JEV-associated encephalitis (Ravi et antibodies al., 1993) , suggesting that it might be responsible for the neural sequelae after acute infection phase. The precise Six-to eight-week-old BALB/c mice were immunized mechanism for JEV persistency in vitro and in vivo has intraperitoneally with JEV-infected suckling mouse brain not been fully understood. One of the possible mechasuspensions mixed with an equal volume of Freund's nisms that have been suggested for other flaviviruses complete adjuvant for first inoculation, and incomplete to persist in cell cultures is the production of defective Freund's adjuvant was used for subsequent boosting. interfering (DI) particles (Brinton, 1986; Poidinger et al., JEV-specific antisera were obtained from the mice after 1991; Schmaljohn and Blair, 1977) . However, the producthree consecutive challenges. For generation of monotion of DI virus has not been universally observed. The clonal antibodies, splenocytes were fused with NS-1 mypresent study describes the establishment of persistent eloma cells and selected as described by Kohler and JEV infection in murine neuroblastoma N18 cells and Milstein (1976) . The hybridoma secreting specific antidemonstrates a novel mechanism of persistent infection bodies were identified by ELISA as described by Heinz involving the synthesis of an abnormal NS1 protein. To et al. (1983) and by immunoprecipitation assays using the best of our knowledge, this is the first report of persis-JEV-infected BHK-21 cell lysates as antigen source. Sintent JEV infection in immortalized neuronal cells. This gle-cell clones were generated by limiting dilution and system provides an in vitro model for studying the molecthe cells were injected into incomplete Freund's adjuular process of persistent JEV infection in neurons. Detervant-primed BALB/c mice for ascitic fluid production. mination of viral and cellular factors involved in the estab-
The specificity of five monoclonal antibodies, D2/8-1, lishment and maintenance of JEV persistency will aid our Na39-3.1, Na41-2, JE7/45-2, and Na81-2.1, against JEV understanding of viral replication and chronic disease NS1 used in this study was further confirmed by Western state of JEV infection.
blotting and immunoprecipitation using antigen source derived from the lysate of BHK-21 cells expressing NS1 MATERIALS AND METHODS by a recombinant plasmid, pJNS1/cDNA3, under CMV promoter control (unpublished data). All five antibodies Cell lines and viruses recognized native forms of NS1, but when the lysate was The cell lines used to establish JEV persistency in this boiled in the presence of 2-mercaptoethanol prior to study were as follows: N18, a mouse neuroblastoma cell SDS-PAGE, only antibody D2/8-1 detected denatured line (Amano et al., 1972 ) (a kind gift from Dr. D. E. Griffin, forms of NS1 (data not shown). These data indicated that Johns Hopkins University, Baltimore MD); Vero, a monkey D2/8-1 recognized a linear epitope of NS1, and that the kidney cell line; and DBT, a mouse astrocytoma cell line remaining antibodies recognized conformational epi- (Hirano et al., 1974) . C2-2 was a clone selected by limiting topes on NS1. The epitope location recognized by D2/8-dilution (see below) from the persistently JEV-infected 1 was characterized by several NS1 deletion mutants N18 cells. All cells were grown in RPMI 1640 medium expressed in BHK-21 cells, and the result showed that containing 10% fetal calf serum (FCS). A JEV strain RP9, the epitope was located in the N-terminal one-third of a plaque-purified virus from a Taiwan local strain NT-NS1 (data not shown). Using synthetic peptides for fine 109 which was originally isolated from infected mosquito mapping, the epitope of D2/8-1 was mapped to a 16-mer Cx. tritaeniorhynchus, was used throughout this study.
peptide whose sequence was TELRYSWKTWGKAKM The propagation of virus was carried out in BHK-21 cells (data not shown); this peptide contained a consensus using RPMI 1640 medium containing 2% FCS. Virus titers linear sequence [WK(A/T)WGK] present in the NS1 of were determined by plaque-forming assay on BHK-21 JEV, Kunjin virus, and dengue virus (Falconar and Young, cells. 1991; Falconar et al., 1994) .
Cloning of persistently infected cells Indirect immunofluorescence staining
Cells were fixed by acetone/methanol (1/1) solution for Limiting dilution was used to clone persistently infected cells. Briefly, the bulk of persistently JEV-infected 5 min, stained with JEV-specific polyclonal or monoclonal antibodies at room temperature for 1 hr. The dilutions of N18 cells was trypsinized and washed once with complete RPMI 1640 medium. Cell suspensions were antibodies used in this assay were 1:500 or 1:1000. After washing with phosphate-buffered saline (PBS), the cells leukemia viral reverse transcriptase (Bethesda Research Laboratories), 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 3 were reacted with goat anti-mouse fluorescein-conjugated secondary antibody (Cappel) and examined under mM MgCl 2 , 10 mM DTT, and 1 mM each dATP, dGTP, dCTP, and dTTP. Using primer sets a and b or c and d, a Leitz fluorescent microscope.
2 ml of the resulting first-strand cDNA sample was PCRCell labeling and immunoprecipitation amplified in 100 ml of reaction mixture containing 5 units of Taq polymerase (Perkin-Elmer); 2 mM MgCl 2 ; 1 mM Cell monolayers were starved with methionine-and each dATP, dGTP, dCTP, and dTTP; 20 mM Tris-HCl (pH cysteine-free RPMI 1640 for 1 hr and labeled with 50 8.4); 50 mM KCl. Thirty-five cycles of amplification were mCi of 35 S Pro-Mix (Amersham) per 35-mm dish for 4 performed by using a PCR thermocycler (AG 9600 Therhr at 37Њ. The cells were rinsed and lysed with lysis mal Station; AcuGen System). Each cycle consisted of a buffer (1% NP-40, 150 mM NaCl, 50 mM Tris -HCl, pH denaturation step at 94Њ for 30 sec followed by a primer-7.5, 1 mM EDTA) containing a cocktail of protease inannealing step at 55Њ for 30 sec and a primer extension hibitors, 20 mg/ml phenylmethylsulfonyl fluoride, 2 mg/ step at 72Њ for 30 sec, except for a longer denaturation ml leupeptin, and 2 mg/ml aprotinin. Aliquots of cell step (5 min) and a longer primer extension step (10 min) lysates were mixed with polyclonal or monoclonal antiat the first and last cycle. bodies captured on Staphylococcal protein A-coated Sepharose (Pharmacia) for 1 hr at room temperature.
DNA sequencing The immune complexes were washed with RIPA buffer (10 mM Tris -HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, PCR products were purified from agarose gel by Qia-0.1% SDS, 1% Triton X-100, 1% sodium deoxycholate), quick gel extraction kit (Qiagen) and sequenced with analyzed by 10% SDS -polyacrylamide gel electrophoSequenase PCR product sequencing kit (United States resis, and fluorographed at 070Њ. et al., 1977) . Cell lysates were mixed with an equal volume of the sample buffer (50 mM Tris-HCl, pH 6.8, 100 mM dithio-RESULTS threitol (DTT), 2% SDS, 0.1% bromophenol blue, 10% glycEstablishment of persistent JEV infection in mouse erol) lacking 2-mercaptoethanol with or without boiling, neuroblastoma N18 cells separated by SDS-PAGE, and transferred to nitrocellulose membrane (Hybond-C Super; Amersham). The non-A mouse neuroblastoma cell line N18 was used to specific antibody-binding sites were blocked with 5% establish a persistent JEV infection in cell culture. Like skimmed milk in PBS, and the filters were incubated with primary infection of BHK-21 cells, JEV is cytolytic to most monoclonal anti-JEV NS1 antibodies. The blot was then N18 cells and the virus yield obtained from this primary treated with horseradish peroxidase-conjugated goat infection was approximately 1 1 10 7 PFU/ml. N18 cells anti-mouse immunoglobulin (Cappel) and developed with were first infected with a plaque-purified JEV strain RP9 4-chloro-1-naphthol.
Biochemical) following the manufacturer's instructions based on the Sanger dideoxynucleotide method (Sanger Western immunoblot analysis
at a multiplicity of infection (m.o.i.) of 10. At 30 hr postinfection (p.i.), severe cytopathic effects (CPE) in infected RNA preparation and RT-PCR reaction cells were observed, and more than 90% of the cells were lysed by 40 hr p.i. The remaining cells from primary Viruses harvested from the media of the JEV-infected cell cultures were incubated with lysis buffer (4 M guani-JEV infection were again infected with JEV at m.o.i. 10 for further selection of surviving cells. After three consecdine thiocyanate, 50 mM Tris-HCl, pH 8.5, 10 mM EDTA, 0.5% sarcosyl) for 15 min at 4Њ and extracted twice with utive cycles of selection, surviving cells were maintained and grown into a stable cell population without apparent an equal volume of acid phenol/chloroform (Chomczynski and Sacchi, 1987) . RNA in the aqueous phase was CPE. The growth rate of this cell population was about 30% slower than the normal N18 cells. To determine precipitated by isopropanol. Four different primers were used in the amplification reaction. Primers a [5-GCGwhether this was a persistent JEV infection in N18 cells, indirect immunofluorescence assay (IFA) using virus-
specific antibodies was carried out to detect viral antigens expressed in these cells; about 90% of the cells [5-GCATTCTCTTTGCCCCGGAATTGGC-3, (/) sense], and d (0) showed microscopically strong positive staining in the cytoplasm (data not shown). In addition, a virus titer of sense] correspond to nucleotides 2478-2501, 3510-3534, 2133-2157, and 2839-2863 of the JEV cDNA, reabout 10 3 to 10 4 PFU/ml was continuously detected in the culture media from bulk cells during the 6-month spectively. Using primer b or d, 5 mg of purified RNA was transcribed into first-strand cDNA at 42Њ for 1 hr in 20 ml period. These results indicated that these cells had been persistently infected with JEV. of reaction buffer containing 200 units of Moloney murine In an attempt to obtain persistently JEV-infected cell the C2-2 clone. Therefore, the antigen-negative clones were indeed cured of viral infection during passages. clones, the bulk cells were cloned by limiting dilution as described under Materials and Methods. Among 31 cell
The susceptibility of C2-2 cells to infection by a heterologous virus, Sindbis virus, which is a prototype alphaviclones established by such a manner, 5 clones were rus, was investigated. Severe CPE and cell death were randomly chosen for further studies, and some of their observed at 12 hr p.i. in C2-2 cells and at 24 hr p.i. in characteristics are shown in Table 1 . During 5-month the parental N18 cells, indicating that C2-2 cells, similar passages, only 1 clone, C2-2, continued to release a low to N18 cells, were susceptible to heterologous viral infectiter of virus into medium, and nearly 100% of cells in tion. Together, these data, including the continuous rethis clone showed positive IFA staining with antibodies lease of infectious virus, the presence of viral antigens against viral proteins (Table 1) . However, as analyzed by and RNA genomes in the cells, and the susceptibility to infectious center assay, only 1% of C2-2 cells were capaheterologous but not homologous viral superinfection, ble of shedding infectious virus. The reason for the disclearly indicate that C2-2 is a bona fide persistently JEVcrepancy between the results of IFA and infectious ceninfected cell clone. ter assay for this clone was unclear (see below under Discussion). The remaining clones had apparently been
Comparison of viral protein expression between cured of viral infection during passages, as evidenced primary and persistent infection by negative IFA staining and lack of viable virus production. The susceptibility of these cell clones to superinfecTo study the expression profiles of viral protein in pertion by homologous viruses was examined (Table 1) .
sistently infected cells, [
35 S]methionine-labeled cell lyAfter superinfection with JEV-RP9 at m.o.i. 50, all 5 clones sates from primary infection of N18 cells and from persisshowed positive IFA staining; however, all but C2-2 tent infection of C2-2 were precipitated by JEV-specific showed severe CPE at 30 hr p.i. and were lysed by 40 antibodies and separated by SDS-PAGE (Fig. 1 ). When hr p.i.; in addition, all of the clones except C2-2 released using monoclonal antibodies specific for either E (Fig. 1 , infectious virus to a titer of about 10 5 PFU/ml into the lanes 3 and 4) or NS3 (Fig. 1, lanes 7 and 8) , the patterns medium ( Table 1 ), indicating that they were susceptible of viral antigen expressions were similar between prito homologous superinfection to almost the same extent mary and persistent infections, although the amounts of as primary infection in N18 cells, although the virus yield proteins varied. It was not clear why there was slightly was slightly lower than that from primary infection of N18 more NS3 precipitated in the C2-2 cells (Fig. 1, lane 8 ) cells (about 5 1 10 7 PFU/ml). By contrast, the C2-2 clone than in the primarily infected N18 cells (lane 7). In conwas resistant to homologous superinfection since no trast, when JEV-specific polyclonal antiserum (Fig. 1 , CPE and no changes in virus titers were observed after lanes 1 and 2) or monoclonal antibodies specific for NS1 superinfection (Table 1) .
( Fig. 1 , lanes 5 and 6) were used, two additional proteins To determine whether all the other clones were indeed with faster mobility, p45 and p39, were observed in per-''cured'' of viral infection, RT-PCR was performed to desistently infected C2-2 cells (lanes 2 and 6), but not in tect the possible existence of viral genome in four viral primarily infected N18 cells (lanes 1 and 5) . antigen-negative clones, C1-1, C1-2, C2-1, and C2-3 (TaTo determine whether this difference in NS1 protein ble 1). The result showed that none of these clones conpattern could also be seen between the C2-2 and the viral antigen-negative cell clones described in Table 1 , tained JEV RNA; in contrast, JEV RNA was detected in . Monomeric NS1, cipitated either with polyclonal antiserum specific for JEV (antiserum, NS1, p45, and p39 are marked by arrows. Molecular weight markers lanes 1 and 2) or with monoclonal antibodies specific for E (aE, lanes in kDa are on the left. 3 and 4), NS1 (aNS1, lanes 5 and 6), or NS3 (aNS3, lanes 7 and 8). The positions of each viral protein in 10% SDS-PAGE are indicated p45 and p39. As expected, only C2-2 cells (Fig. 2, lane by arrows. Note that two additional proteins, p45 and p39, were found 9) and not the other clones (Fig. 2, lanes 6 to 8 and 10 ), in C2-2 cell lysates when precipitated by polyclonal antiserum (lane 2) and by anti-NS1 monoclonal antibodies (lane 6).
expressed NS1 protein in the absence of JEV superinfection, consistent with the result of immunofluorescence described in Table 1 . These results indicate that the abwe carried out immunoprecipitation of NS1 in the six normal NS1 expression in C2-2 cells is a property associclones after superinfection with JEV (Fig. 2) . All four antiated with persistently infected viral genome. gen-negative clones expressed normal NS1 and NS1
To determine whether the truncation of the NS1 was (Fig. 2, lanes 1 to 3 and 5) , whereas only C2-2 (Fig. 2, an inherent property of the viruses released from the lane 4) produced the two additional abnormal proteins, persistently infected C2-2 cells, fresh N18 cells were infected with these viruses and the pattern of NS1 proteins in the infected cells was analyzed. To eliminate the possible influence from DI particles, the released viruses from C2-2 were first amplified once in BHK-21 cells at m.o.i. 0.01. Similar to the primary JEV infections, the primary infection of N18 cells with the viruses released from C2-2 resulted in lytic infection after 30-hr incubation, and no abnormal forms of NS1 proteins were detected in the infected cells (data not shown). These results suggested that the aberrant NS1 expression was not an inherent property of the viruses released from C2-2 cells, but most likely the result of virus-cell interaction associated with persistent infection.
Characterization of the truncated NS1 proteins from persistently infected C2-2 cells shown in Fig. 3 , when protein samples were heat-dena-NS1s in C2-2 cells. Both NS1 and NS1 contain two predicted glycosylation sites at the amino acid positions 105 and 182 (Fig. 5A) , and glycosylated moieties are about 6 kDa in mass. After complete digestion by endoglycosylase F (Endo F), the sizes of NS1 and NS1 decreased from 48 to 42 kDa and from 55 to 49 kDa, respectively, as expected (compare Fig. 5B , lane 1 with 4, and 2 with 5). Interestingly, both p45 and p39 also were susceptible to Endo F digestion: their sizes were reduced from 45 to 40 kDa and from 39 to 33 kDa, respectively, after Endo F digestion (Fig. 5B , compare lane 3 with 6). These results suggest that, in C2-2 cells, (i) the generation of the truncated NS1s did not interfere with the normal glycosylation of wild-type NS1 and NS1; (ii) the truncated NS1s, like their wild-type counterparts, are translocated into ER and glycosylated; and (iii) the proteins of p45 and p39 are positioned by asterisks.
Detection of truncated NS1 in other persistently JEVinfected cells tured prior to electrophoresis, the monomeric forms of
To determine whether the truncation of NS1 and NS1 NS1 and NS1 of normal sizes were both detected in is a general characteristic of JEV persistent infection, primary infection of N18 (lane 2). In C2-2 cells, both p45 and p39, in addition to the normal NS1 and NS1, were detected (lane 4). In the absence of heat denaturation, all of the NS1 migrated as the homo-and heterodimeric forms (Fig. 3, lanes 3 and 5) (Lee et al., 1991; Fan and Mason, 1990; Flamand et al., 1992) . These results clearly indicate that both p45 and p39 are the truncated forms of JEV NS1.
To further understand the structure of p45 and p39, we performed immunoprecipitation using five different anti-NS1 monoclonal antibodies (see Materials and Methods). Among them, four monoclonal antibodies, Na39-3.1, Na41-2, JE7/45-2, and Na81-2.1, have previously been shown to recognize conformational epitopes of NS1 although the precise epitopes have not been mapped (see Materials and Methods). The results ( Fig. 4B) . In contrast, monoclonal antibody D2/8-1, which
The expected changes of molecular weights from precipitated NS1s has been characterized to recognize a linear epitope treated either without (0) and not the truncated NS1s (Fig. 4B, lane 5) . This result either without (lanes 1 to 3) or with (lanes 4 to 6) Endo F at 37Њ for 16 strongly suggests that both p45 and p39 observed in C2-hr. The deglycosylated NS1 and NS1 (lanes 4 to 6) are indicated by 2 cells are truncated at their N-termini.
arrows, and the deglycosylated truncated p45 and p39 (lane 6) are marked by asterisks.
We next examined the glycosylation status of truncated cipitated by antiserum, extra protein bands migrating faster than the normal NS1 were detected from all persistent infections of C2-2 (Fig. 6, lane 2) , Vero (lane 3), and DBT cells (lane 8). These abnormal proteins were truncated NS1 proteins, as demonstrated by immunoprecipitation by monoclonal antibodies against NS1. In persistently infected Vero cells, two faster migrating proteins (Fig. 6, lane 6) , which closely resembled the truncated NS1s p45 and p39, seen in C2-2 cell lysate, were detected (lane 5). As a control, primary infection of Vero cells did not express these faster migrating proteins (data not shown). In contrast, in persistently infected DBT cells only one species of faster migrating protein was detected (Fig. 6, lane 10) . Again, this truncated NS1 protein was not detected in primary infection (Fig. 6, lane  9) . Taken together, these results clearly indicate a strong relationship between abnormal NS1 expression and JEV persistency in cell cultures. primer pairs as described in Fig. 7A . The positions of primers chosen were based on the assumption that the truncated NS1s should still contain the signal peptides we examined the NS1 protein in two other persistently at their N-termini (Flamand et al., 1992) in order to be infected cell lines established in Vero and DBT cells. translocated into the ER for proper glycosylation. As demThe establishment of JEV persistency in Vero cells was onstrated in Fig. 7B , both C2-2 cells and primary infection similar to that in N18 cells; primary infection of JEV of N18 cells yielded PCR products of identical sizes; no causes a severe CPE in Vero cells at 30 hr p.i., and ú90% truncated PCR products were detected in C2-2 cells (Fig. of the infected cells were lysed at 40 hr p.i. Surviving 7B, lanes 2 to 5). To detect mutations, we directly secells were grown into a cell population and showed a quenced the RT-PCR products purified from agarose gel slight morphological change. The growth rate of these in Fig. 7B , lanes 4 and 5. Primer d (Fig. 7A ) was used cells was about 30% slower than that of the uninfected here as a sequencing primer to analyze the sequences Vero cells. JEV persistency in these Vero cells was veriaround the junction of the predicted truncation site on fied by positive IFA staining of viral protein and continu-NS1. The results demonstrated that no mutation was ous release of infectious virus for more than 3 months found in the PCR products from persistent infection of (data not shown). By contrast, the establishment of JEV C2-2 cells, compared to that from primary infection of N18 persistency in DBT cells was significantly different from cells (data not shown). Moreover, the sequence result of that in N18 and Vero cells. After infection, no obvious PCR products purified from Fig. 7B , lanes 2 and 3, which CPE was seen in DBT cells, although the infected cells cover the entire NS1-coding region, revealed that no mugrew about 30% slower than did uninfected DBT cells.
tation was found in NS1 from C2-2 cells compared to During passages, such infected DBT cells were periodithat from primary infection of N18 cells (data not shown). cally checked for their viral antigen expression and virus Thus, these results suggest that the truncations of NS1 release; about 90% of the cells were shown to have posiand NS1 seen in persistent infection of C2-2 cells did tive IFA staining in the cytoplasm (data not shown), and not result from the mutations of the NS1 gene in the virus titers ranging from 10 4 to 10 5 were detected in culviral RNA, but most likely resulted from posttranslational ture media for more than 3 months. These results indicleavage caused by defects in other genes. cate that these cells were persistently infected with JEV.
NS1 expressed in persistently JEV-infected Vero and DISCUSSION DBT cells was investigated by immunoprecipitation using virus-specific antiserum (see Materials and Methods)
We have successfully established persistent JEV infection in murine neuroblastoma cells (N18), murine astrocyand anti-NS1 monoclonal antibodies (Fig. 6) . When pre-the failure of antibody D2/8-1 to recognize p45 and p39 (Fig. 4) and (ii) the possession of normal glycosylated moieties of the truncated p45 and p39, similar to that of their counterpart wild-type NS1s (Fig. 5) . However, our data indicated that no mutation was detected in the NS1 region of the viral genome in C2-2 cells, suggesting that the truncations of NS1 and NS1 seen in C2-2 cells did not result from the mutations in the NS1 gene, but most likely resulted from posttranslational cleavage caused by defects in other genes. It is necessary in the future to examine whether there is mutation in other viral genes leading to aberrant expression of NS1 in C2-2 cells.
The biosynthesis of flavivirus NS1 has been demonstrated to utilize the cellular secretory pathway, i.e., ER and Golgi complex (Mason, 1989; Fan and Mason, 1990; Blitvich et al., 1995) . Conceivably, the truncation of NS1 in C2-2 cells was a result of an aberrant proteolytic cleavage, which occurred within ER or Golgi apparatus after the translocation of NS1. The protease responsible for this cleavage is unlikely to be the known viral protease or an effect of JEV persistency in cell cultures remains unclear. Nonetheless, our data do indicate that the expression of truncated NS1s is a dominant phenotype (Fig.  toma cells (DBT) , and Vero cells. In particular, the estab-2) associated with the maintenance of JEV persistency lishment of viral persistency in the C2-2 cell clone, dein a variety of cell lines. The establishment of persistent rived from the persistently infected N18 cells, provides infection is a dynamic process as a result of interaction an important system for studying the persistent JEV infecbetween virus and host. The NS1 truncation could be a tion in neuronal cells. The main finding of this study result of change of host cells, altering the specificity of is the detection of truncated NS1s which were tightly viral or cellular proteases. Conceivably, JEV persistency associated with JEV persistency in various cell lines. We in C2-2 cell requires the relative ratio between the wildhave recently also observed an aberrant NS1 expression type and the truncated NS1s to regulate the balance in the persistent JEV infection of NT2 cells, a human between lytic infection and temperate persistency, preneuronal progenitor cell line (unpublished observation).
sumably through interfering with the process of viral asThe generality of this abnormal NS1 expression pattern sembly when nucleocapsid buds into the lumen of the associated with all of the persistently infected cells stud-ER (reviewed in Chambers et al., 1990) . This hypothesis ied so far strongly suggests that NS1 plays a crucial role is supported in part by our observation that both the wildin JEV persistency. Thus, the aberrant NS1 expression type and the truncated NS1s were detected in all of the pattern may be used as a molecular marker for the identipersistently infected cell lines (Fig. 6 ). In addition, flavification of JEV persistency. viral NS1 protein has been suggested to play a role in The truncation of NS1s in C2-2 cells likely resides in the process of virion assembly or maturation within the cellular secretory pathway (Mason, 1989; Fan and Matheir N-terminal 105th amino acid, as evidenced by (i) son, 1990 ). This interpretation is also consistent with the between abnormal NS1 expression and JEV persistency; (iv) the truncation of NS1 in C2-2 cells probably resulted finding that all of the cells showed positive viral antigen staining and yet only 1% of cells released viruses in the from an additional posttranslational proteolytic cleavage occurring in the persistently infected cells; and (v) these infectious cell center, and the culture produced very low virus titers (Table 1) .
results suggest a probable involvement of dysfunctional NS1 in the establishment and/or maintenance of JEV perThe shift from cytolytic infection to persistent infection in a susceptible cell must be occurring under strong sistency in culture systems. selective pressures on both the virus and the host. As suggested for reovirus persistency (Ahmed et al., 1981) , ACKNOWLEDGMENTS in order for virus to persist in cell culture, on one hand this hypothesis, the observation that the four antigennegative cell clones (Table 1) showed reductions of the virus production when superinfected with JEV suggests REFERENCES that they may be the relics of mutated cells selected tion. Moreover, the antigen-positive clone C2-2 likely repBaczko, K., Lampe, J., Liebert, U. G., Brinckmann, U., ter Meulen, V., resents a successful endpoint of the mutation course, Pardowitz, I., Budka, H., Cosby, S. L., Isserte, S., and Rima, B. K. which survives simply because it properly balances the (1993) . Clonal expansion of hypermutated measles virus in a SSPE brain. Virology 197, [188] [189] [190] [191] [192] [193] [194] [195] dilemma between the cytolytic and the persistent infec-
